<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502656</url>
  </required_header>
  <id_info>
    <org_study_id>RASANC</org_study_id>
    <nct_id>NCT02502656</nct_id>
  </id_info>
  <brief_title>RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer</brief_title>
  <acronym>RASANC</acronym>
  <official_title>RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer: Concordance With the &quot;Standard&quot; Testing Method From Tumor Tissue and Review of Associated Timelines and Costs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association des Gastroentérologues Oncologues</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association des Gastroentérologues Oncologues</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the concordance of RAS mutation detection between the results
      obtained from circulating tumor DNA and those obtained with the &quot;standard&quot; method (testing
      from tumor tissue).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance regarding the mutation of RAS (yes vs no, dichotomous variable) between the two methods</measure>
    <time_frame>Baseline</time_frame>
    <description>RAS mutations will be compared between tumor tissue (standard testing methods) and results obtained from circulating tumor DNA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concordance regarding the mutation of RAS (yes vs no, dichotomous variable) between the two methods in patients for whom circulating tumor DNA has been identified in the avalaible plasma sample.</measure>
    <time_frame>Baseline</time_frame>
    <description>RAS mutations will be compared between tumor tissue (standard testing methods) and results obtained from circulating tumor DNA. This subgroup of patients is defined as patients with at least one mutation identified in the panel of tested genes (Ion AmpliSeq Colon and Lung Cancer Panel) (RAS mutation or mutations on other genes TP53, PIK3CA, SMAD4 .... ) or with at least one methylated biomarker identified (for patients with no mutation identified in the panel of genes tested).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the timelines to obtain results between the two methods</measure>
    <time_frame>Baseline</time_frame>
    <description>Timelines to obtain RAS mutations will be compared between tumor tissue (standard testing methods) and circulating tumor DNA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparisons of the costs between the two methods</measure>
    <time_frame>Baseline</time_frame>
    <description>Costs for the two methods will be compared between tumor tissue (standard testing methods) and circulating tumor DNA</description>
  </secondary_outcome>
  <enrollment type="Anticipated">425</enrollment>
  <condition>Colorectal Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood collection will be performed on the day of the first oncological consultation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All treatment naive patients seen in consultation for metastatic colorectal cancer in the
        participating centers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pathologically confirmed metachronous or synchronous metastatic colorectal cancer

          -  No prior chemotherapy with the exception of adjuvant chemotherapy completed ≥ 6 months
             prior to enrollment

          -  Signed written informed consent obtained prior to any study specific screening
             procedures

          -  Patients willing to provide a blood sample for Translational Research

        Exclusion Criteria:

          -  No tumor block available

          -  Previous malignancy in the last 5 years

          -  Medical, sociological, psychological or legal conditions that would not permit the
             patient to sign informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Baptiste Bachet, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Association des Gastro-entérologues Oncologues (AGEO)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Baptiste Bachet, Dr</last_name>
    <email>jean-baptiste.bachet@psl.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Avicenne</name>
      <address>
        <city>Bobigny</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Aparicio, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Béclère</name>
      <address>
        <city>Clamart</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>L Marthey, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christophe Tournigand, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Kremlin-Bicêtre</name>
      <address>
        <city>Kremlin-Bicêtre</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Thirot- Bidault, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Longjumeau et Sud</name>
      <address>
        <city>Longjumeau</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Ezenfis, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Mermoz</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gérard Lledo, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Cochin</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Romain Coriat, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry André, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hopital Saint-Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Marc Gornet, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien Taieb, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Baptiste Bachet, Dr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Poitiers</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Tougeron, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Robert Debré</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Bouché, Pr</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Trousseau</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry Lecomte, Pr</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>November 16, 2016</last_update_submitted>
  <last_update_submitted_qc>November 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>RAS mutation</keyword>
  <keyword>DNA</keyword>
  <keyword>Colorectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

